Evidence of NAFLD progression from steatosis to fibrosing-steatohepatitis using paired biopsies: Implications for prognosis and clinical management

Journal of Hepatology

Volumn 62, Issue 5, 2015, Pages 1148-1155

  McPherson, Stuart ^a,b   Hardy, Tim ^a   Henderson, Elsbeth ^b   Burt, Alastair D ^a,b   Day, Christopher P ^a,b   Anstee, Quentin M ^a,b  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b FREEMAN HOSPITAL   (United Kingdom)

Author keywords

Cirrhosis; Fibrosis; NAFLD; NASH; Steatohepatitis

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; FERRITIN; GAMMA GLUTAMYLTRANSFERASE; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; COHORT ANALYSIS; DISEASE COURSE; DISEASE SEVERITY; FEMALE; FOLLOW UP; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOGLOBULIN BLOOD LEVEL; LIVER BIOPSY; LIVER CELL; LIVER FIBROSIS; LIVER FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; NONALCOHOLIC FATTY LIVER; NONALCOHOLIC FATTY LIVER DISEASE ACTIVITY SCORE; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; BIOPSY; FATTY LIVER; GREAT BRITAIN; LIVER CIRRHOSIS; NON-ALCOHOLIC FATTY LIVER DISEASE; PATHOLOGY; PATHOPHYSIOLOGY; PROCEDURES; RISK FACTOR; SEVERITY OF ILLNESS INDEX;

ADULT; BIOPSY; DISEASE PROGRESSION; FATTY LIVER; FEMALE; FOLLOW-UP STUDIES; GREAT BRITAIN; HUMANS; LIVER CIRRHOSIS; MALE; MIDDLE AGED; NON-ALCOHOLIC FATTY LIVER DISEASE; RISK FACTORS; SEVERITY OF ILLNESS INDEX;

EID: 84927796763     PISSN: 01688278     EISSN: 16000641     Source Type: Journal    
DOI: 10.1016/j.jhep.2014.11.034     Document Type: Article

References (38)

1. Q.M. Anstee, S. McPherson, and C.P. Day How big a problem is non-alcoholic fatty liver disease? BMJ 343 2011 d3897
2. M.J. Armstrong, D.D. Houlihan, L. Bentham, J.C. Shaw, R. Cramb, and S. Olliff Presence and severity of non-alcoholic fatty liver disease in a large prospective primary care cohort J Hepatol 56 2012 234 240
3. Q.M. Anstee, G. Targher, and C.P. Day Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis Nat Rev Gastroenterol Hepatol 10 2013 330 344
4. J.M. Clark, and A.M. Diehl Defining nonalcoholic fatty liver disease: implications for epidemiologic studies Gastroenterology 124 2003 248 250
5. J.G. Fan, J. Zhu, X.J. Li, L. Chen, L. Li, and F. Dai Prevalence of and risk factors for fatty liver in a general population of Shanghai, China J Hepatol 43 2005 508 514
6. S. Bellentani, G. Saccoccio, F. Masutti, L.S. Croce, G. Brandi, and F. Sasso Prevalence of and risk factors for hepatic steatosis in Northern Italy Ann Intern Med 132 2000 112 117
7. J.D. Browning, L.S. Szczepaniak, R. Dobbins, P. Nuremberg, J.D. Horton, and J.C. Cohen Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity Hepatology 40 2004 1387 1395
8. N. Chalasani, Z. Younossi, J.E. Lavine, A.M. Diehl, E.M. Brunt, and K. Cusi The diagnosis and management of non-alcoholic fatty liver disease: practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association Hepatology 55 2012 2005 2023
9. Y.L. Liu, G.L. Patman, J.B. Leathart, A.C. Piguet, A.D. Burt, and J.F. Dufour Carriage of the PNPLA3 rs738409 C >G polymorphism confers an increased risk of non-alcoholic fatty liver disease associated hepatocellular carcinoma J Hepatol 6 2014 75 81
10. N. Bhala, P. Angulo, D. van der Poorten, E. Lee, J.M. Hui, and G. Saracco The natural history of nonalcoholic fatty liver disease with advanced fibrosis or cirrhosis: an international collaborative study Hepatology 54 2011 1208 1216
11. M.S. Ascha, I.A. Hanouneh, R. Lopez, T.A. Tamimi, A.F. Feldstein, and N.N. Zein The incidence and risk factors of hepatocellular carcinoma in patients with nonalcoholic steatohepatitis Hepatology 51 2010 1972 1978
12. A.J. Sanyal, C. Banas, C. Sargeant, V.A. Luketic, R.K. Sterling, and R.T. Stravitz Similarities and differences in outcomes of cirrhosis due to nonalcoholic steatohepatitis and hepatitis C Hepatology 43 2006 682 689
13. J. Dyson, B. Jaques, D. Chattopadyhay, R. Lochan, J. Graham, and D. Das Hepatocellular cancer: the impact of obesity, type 2 diabetes and a multidisciplinary team J Hepatol 60 2014 110 117
14. Q.M. Anstee, and C.P. Day The genetics of NAFLD Nat Rev Gastroenterol Hepatol 10 2013 645 655
15. L. Valenti, A. Al-Serri, A.K. Daly, E. Galmozzi, R. Rametta, and P. Dongiovanni Homozygosity for the patatin-like phospholipase-3/adiponutrin I148M polymorphism influences liver fibrosis in patients with nonalcoholic fatty liver disease Hepatology 51 2010 1209 1217
16. Y.L. Liu, H.L. Reeves, A.D. Burt, D. Tiniakos, S. McPherson, and J.B. Leathart TM6SF2 rs58542926 influences hepatic fibrosis progression in patients with non-alcoholic fatty liver disease Nat Commun 5 2014 4309
17. S. Singh, A.M. Allen, Z. Wang, L.J. Prokop, M.H. Murad, and R. Loomba Fibrosis progression in nonalcoholic fatty liver vs. nonalcoholic steatohepatitis: a systematic review and meta-analysis of paired-biopsy studies Clin Gastroenterol Hepatol 2014 10.1016/j.cgh.2014.04.014 [Epub ahead of print]
18. E.E. Powell, W.G. Cooksley, R. Hanson, J. Searle, J.W. Halliday, and L.W. Powell The natural history of nonalcoholic steatohepatitis: a follow-up study of forty-two patients for up to 21 years Hepatology 11 1990 74 80
19. E. Fassio, E. Alvarez, N. Dominguez, G. Landeira, and C. Longo Natural history of nonalcoholic steatohepatitis: a longitudinal study of repeat liver biopsies Hepatology 40 2004 820 826
20. V.W. Wong, G.L. Wong, P.C. Choi, A.W. Chan, M.K. Li, and H.Y. Chan Disease progression of non-alcoholic fatty liver disease: a prospective study with paired liver biopsies at 3 years Gut 59 2010 969 974
21. S.A. Harrison, S. Torgerson, and P.H. Hayashi The natural history of nonalcoholic fatty liver disease: a clinical histopathological study Am J Gastroenterol 98 2003 2042 2047
22. C.K. Argo, and S.H. Caldwell Epidemiology and natural history of non-alcoholic steatohepatitis Clin Liver Dis 13 2009 511 531
23. L.A. Adams, S. Sanderson, K.D. Lindor, and P. Angulo The histological course of nonalcoholic fatty liver disease: a longitudinal study of 103 patients with sequential liver biopsies J Hepatol 42 2005 132 138
24. M.R. Teli, C.P. Day, A.D. Burt, M.K. Bennett, and O.F. James Determinants of progression to cirrhosis or fibrosis in pure alcoholic fatty liver Lancet 346 1995 987 990
25. M. Ekstedt, L.E. Franzen, U.L. Mathiesen, L. Thorelius, M. Holmqvist, and G. Bodemar Long-term follow-up of patients with NAFLD and elevated liver enzymes Hepatology 44 2006 865 873
26. R. Pais, F. Charlotte, L. Fedchuk, P. Bedossa, P. Lebray, and T. Poynard A systematic review of follow-up biopsies reveals disease progression in patients with non-alcoholic fatty liver J Hepatol 59 2013 550 556
27. R.K. Sterling, E. Lissen, N. Clumeck, R. Sola, M.C. Correa, and J. Montaner Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection Hepatology 43 2006 1317 1325
28. P. Angulo, J.M. Hui, G. Marchesini, E. Bugianesi, J. George, and G.C. Farrell The NAFLD fibrosis score: a noninvasive system that identifies liver fibrosis in patients with NAFLD Hepatology 45 2007 846 854
29. J.K. Dyson, S. McPherson, and Q.M. Anstee Non-alcoholic fatty liver disease: non-invasive investigation and risk stratification J Clin Pathol 66 2013 1033 1045
30. D.E. Kleiner, E.M. Brunt, M. Van Natta, C. Behling, M.J. Contos, and O.W. Cummings Design and validation of a histological scoring system for nonalcoholic fatty liver disease Hepatology 41 2005 1313 1321
31. M.M. Yeh, and E.M. Brunt Pathological features of fatty liver disease Gastroenterology 147 2014 754 764
32. N. Rafiq, C. Bai, Y. Fang, M. Srishord, A. McCullough, and T. Gramlich Long-term follow-up of patients with nonalcoholic fatty liver Clin Gastroenterol Hepatol 7 2009 234 238
33. S. McPherson, E. Henderson, A.D. Burt, C.P. Day, and Q.M. Anstee Serum immunoglobulin levels predict fibrosis in patients with non-alcoholic fatty liver disease J Hepatol 60 2014 1055 1062
34. S. McPherson, Q.M. Anstee, E. Henderson, C.P. Day, and A.D. Burt Are simple noninvasive scoring systems for fibrosis reliable in patients with NAFLD and normal ALT levels? Eur J Gastroenterol Hepatol 25 2013 652 658
35. S. McPherson, S.F. Stewart, E. Henderson, A.D. Burt, and C.P. Day Simple non-invasive fibrosis scoring systems can reliably exclude advanced fibrosis in patients with non-alcoholic fatty liver disease Gut 59 2010 1265 1269
36. A.G. Shah, A. Lydecker, K. Murray, B.N. Tetri, M.J. Contos, A.J. Sanyal Nash Clinical Research Network Comparison of noninvasive markers of fibrosis in patients with nonalcoholic fatty liver disease Clin Gastroenterol Hepatol 7 2009 1104 1112
37. P. Angulo, E. Bugianesi, E.S. Bjornsson, P. Charatcharoenwitthaya, P.R. Mills, and F. Barrera Simple noninvasive systems predict long-term outcomes of patients with nonalcoholic fatty liver disease Gastroenterology 145 2013 e784
38. V. Ratziu, F. Charlotte, A. Heurtier, S. Gombert, P. Giral, and E. Bruckert Sampling variability of liver biopsy in nonalcoholic fatty liver disease Gastroenterology 128 2005 1898 1906